UK biotechs struggle to find cash

In a BioIndustry Association survey of 295 UK-based companies, more than three quarters of respondents that access to capital had become more challenging over the last 12 months. Seventy-six percent of companies seeking to raise equity finance have experienced some level of difficulty; of these, 47 percent were not able to obtain all the finance required and a further 37 percent were unable to obtain any finance. Release